financetom
Business
financetom
/
Business
/
Coty expects quarterly sales at top end of forecast on steady fragrance demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coty expects quarterly sales at top end of forecast on steady fragrance demand
Nov 5, 2025 2:07 PM

(Reuters) -CoverGirl-parent Coty ( COTY ) forecast like-for-like sales for the second quarter at the top end of its prior outlook, betting on steady demand for Calvin Klein and Hugo Boss fragrances even as customers curb spending on broader makeup and skincare items.

Shares of the company, which had previously forecast second-quarter sales to fall between 3% and 5%, were up about 8% in extended trading on Wednesday. They have fallen about 45% so far this year.

Coty ( COTY ) said earlier this year it has launched a strategic review of its beauty business that could lead to the sale of brands such as Rimmel and CoverGirl, as it aims to refocus on its fragrances segment amid persistently weak demand for color cosmetics.

Fragrances and scenting is a very resilient category for Coty ( COTY ), and is performing well across the spectrum from $5 mass options to ultra-premium at $500, Chief Financial Officer Laurent Mercier said in an interview with Reuters.

Last week, peer Estee Lauder ( EL ) also signaled strong demand for its fragrances and an uptick in China.

Coty ( COTY ), however, missed first-quarter profit estimates as retailers cut back on orders amid ongoing macroeconomic and tariff uncertainty.

French beauty conglomerate and industry leader L'Oreal, which is set to buy Kering's beauty business, including rights to Gucci, reported weaker-than-expected third-quarter sales last month, weighed down by its performance in North America and Latin America.

Coty ( COTY ), which currently holds the licensing to Gucci Beauty, will continue to operate the brand for the term of the agreement, Mercier said.

The company posted adjusted profit per share of 12 cents during the first quarter, compared with analysts' average estimate of 15 cents, according to data compiled by LSEG. Its net sales fell 6% to $1.58 billion.

For the second quarter, it forecast adjusted profit between 18 and 21 cents per share, while analysts expected 19 cents.

Coty ( COTY ) shares have fallen nearly 46% so far this year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-Worldline attracts early stage interest from private equity firms, sources say
Exclusive-Worldline attracts early stage interest from private equity firms, sources say
Dec 3, 2024
LONDON (Reuters) -French payments group Worldline has attracted early stage takeover interest from private equity firms, as it grapples with a falling share price, profit warnings and leadership change, five people with knowledge of the matter said. Bain Capital is among private equity firms that have been in the initial stages of evaluating a possible bid for Worldline, two of...
Alaska Energy Metals Extends Higher-Grade Core Zone Mineralization at Nikolai Project in Alaska
Alaska Energy Metals Extends Higher-Grade Core Zone Mineralization at Nikolai Project in Alaska
Dec 3, 2024
08:52 AM EST, 12/03/2024 (MT Newswires) -- Alaska Energy Metals ( AKEMF ) on Tuesday said it has received assay results from two of four drill holes completed during the 2024 Eureka resource expansion drill program at the Nikolai project in Alaska. Assay results confirm the continuation of the higher-grade core zone about 600 meters to the southeast, the company...
Corbus Pharmaceuticals' CRB-701 Gets FDA Fast Track Designation for Treatment of Cervical Cancer
Corbus Pharmaceuticals' CRB-701 Gets FDA Fast Track Designation for Treatment of Cervical Cancer
Dec 3, 2024
08:59 AM EST, 12/03/2024 (MT Newswires) -- Corbus Pharmaceuticals Holdings ( CRBP ) said Tuesday that CRB-701 has received fast track designation from the US Food and Drug Administration for the treatment of relapsed or refractory metastatic cervical cancer. The company said the designation aims to facilitate the development and hasten the review of drugs that have the potential to...
Market Chatter: Vale to Keep 2025 Iron Ore Production Steady
Market Chatter: Vale to Keep 2025 Iron Ore Production Steady
Dec 3, 2024
08:54 AM EST, 12/03/2024 (MT Newswires) -- Vale (VALE) is looking to keep its iron ore production levels little changed next year at 325 million to 335 million metric tons, Bloomberg News reported, citing disclosures for the company's investor event on Tuesday. Vale expects to produce about 328 million tons this year, the report said. (Market Chatter news is derived...
Copyright 2023-2026 - www.financetom.com All Rights Reserved